Insights AI
The market’s most important stocks, simplified
Why is Moderna Inc stock underperforming the market?
This content was created in whole or in part using Generative Artificial Intelligence (AI). Please read the disclosures found at the end of this content for more information.
Ready to make your move?
You’ve seen the news. It’s time to set your strategy. The TradeStation ecosystem is designed to execute your trades no matter how unique or complex. Set your strategy in motion with the advanced tools and brokerage services built specifically for those who are born to trade
Recent news for MRNA
By clicking one of the links below, you are leaving TradeStation.com.
Vinay Prasad's Appointment To FDA's CBER Triggers Questions Over Future Of Cell And Gene Therapy Regulation
FDA names Vinay Prasad to lead CBER, raising questions over biologics oversight and triggering biotech stock losses and analyst concerns.
Moderna Expands Cost-Cutting Program By Up To $1.7 Billion, FDA Approval For Flu/COVID-19 Combo Shot Delayed Into 2026
Moderna reaffirms 2025 revenue guidance of $1.5 billion–$2.5 billion, cuts 2027 cost forecast by up to $1.7 billion, and targets 2026 approval for its flu/COVID combo shot.
About MRNA
Moderna is a commercial-stage biotech that was founded in 2010 and had its initial public offering in December 2018. The firm's mRNA technology was rapidly validated with its covid vaccine, which was authorized in the United States in December 2020. ... Read more
Ways to trade options* on MRNA
Bearish Option Strategy: Put Spread
Traders buy a put option near the money and sell another at a lower strike. This strategy can leverage a price drop with limited capital at risk.
- 1
- 2
- 3
Insights AI filters through the noise to uncover meaningful data that natural-born traders can use to find new trading opportunities. Our AI model distills complex market news and data into accessible, actionable intelligence. Stay informed of market moves with curated trading intelligence and platform tips delivered directly to you.
The symbols selected include stocks that meet a specific set of criteria: the 50 most active stocks based on 21-day options volume. ETFs and meme stocks are not included.
This Content was created in whole or in part using Generative Artificial Intelligence (AI). While efforts have been made to ensure accuracy, the Content is generated autonomously by AI algorithms and it may contain errors or inaccuracies. Users are advised to critically evaluate the information presented.
This Content is for educational and informational purposes only. Any symbols or trading strategies discussed are for demonstration purposes only and are not research or recommendations.
TradeStation Group, Inc. (“TradeStation”) pays third parties for the data and other information included on this page (the “Content”). The Content is derived from news and other information feeds provided by Accretive Capital LLC d/b/a Benzinga (“Benzinga”) and market activity. Benzinga is not affiliated with TradeStation. TradeStation makes the Content available for informational purposes only. The Content should not be considered an offer or solicitation tobuy, sell, or hold any investment/security. The Content is believed to be from reliable sources; however, TradeStation does not verify all of the information included in the Content for accuracy or completeness. TradeStation does not endorse any third-party content, and any views or opinions expressed in the Content do not necessarily represent the views and opinions of TradeStation. Any goods or services offered by Benzinga are not sponsored, endorsed, sold, or promoted by TradeStation, and TradeStation makes no representation regarding any such goods or services.
TradeStation does not endorse or adopt the Content, and makes no guarantees that the Content is accurate, complete, or timely. TradeStation assumes no responsibility for the accuracy, completeness, updates, changes, or timeliness of the Content. TradeStation does not provide investment, tax or legal advice. Any recommendation, opinion or advice regarding securities or markets contained in the Content does not reflect the views of TradeStation. TradeStation assumes no responsibility for any fact, recommendation, opinion or advice contained in the Content and expressly disclaims any responsibility for any decisions based upon any such Content.
Any decisions you may make to buy, sell or hold a security or other investment based on the Content or other third-party information will be entirely your own and not in any way deemed to be endorsed, influenced by or attributed to TradeStation. It is understood that, without exception, any order based on the Content that is placed with TradeStation for execution should be considered by you to be an unrecommended and unsolicited order. TradeStation will treat all such orders as unsolicited.
*Options trading is not suitable for all investors. Your TradeStation Securities’ account application to trade options will be considered and approved or disapproved based on all relevant factors, including your trading experience. See www.TradeStation.com/DisclosureOptions. Visit www.TradeStation.com/Pricing for full detailson the costs and fees associated with options.
